1 / 1

Efficacy of Renal Denervation in Resistant Hypertension Over 12 Months

This study analyzes the impact of renal denervation on patients with treatment-resistant hypertension, highlighting significant reductions in office systolic blood pressure (SBP) by ≥10 mm Hg and ambulatory blood pressure (ABP) by ≥5 mm Hg. In this cohort, responder rates were observed at 80%, with efficacy measured at 3, 6, and 12 months. The findings emphasize the potential of renal denervation as a viable intervention for managing difficult-to-treat hypertension, providing insights into long-term treatment outcomes.

geraldine-travis
Download Presentation

Efficacy of Renal Denervation in Resistant Hypertension Over 12 Months

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. 100 Reduction of office SBP ≥ 10 mm Hg Reduction of ABP ≥ 5 mm Hg 80 Rates of responders to renaldenervation in patientswithtruetreatment-resistanthypertension 60 76,7 73,3 71,3 70 Proportion (%) 65 58,3 40 20 0 3 months 6 months 12 months Mahfoudet al. Circulation 2013

More Related